Connect with us

U.S.

COVID-19 May Have Been in the U.S. December 2019, New Study Shows

Published

on

  • A new government report found that the coronavirus may have been in the United States in December 2019, weeks before the first confirmed case.
  • For the study, the CDC looked at over 7,000 blood samples taken in nine states between December 13, 2019 and January 12, 2020.
  • Researches found COVID-19 antibodies in 106 of those samples, with at least one sample per state having antibodies.
  • These findings are in line with several other studies in the U.S. and well other countries which have found that the coronavirus was likely spreading globally before health officials were aware of it.

Report Shows Potential U.S. Cases in December

COVID-19 may have made its way to the United States in December of 2019, weeks earlier than previously thought, according to a new government study. 

That study was published Monday in the Clinical Infectious Diseases journal. The first coronavirus case was reported in Wuhan, China at the end of December. The first case in the United States was not reported until mid-January, but health experts have long wondered if the disease had been spreading sooner than that. 

For the study, the Centers for Disease Control and Prevention looked at 7,389 blood donations collected by the American Red Cross between December 13, 2019 and January 17, 2020 from donors across nine states.  Of those samples, antibodies showed up in 106. Antibodies came up from people in each state, with 39 coming from California, Oregon and Washington and the other 67 coming from Massachusetts, Wisconsin, Iowa, Michigan, Connecticut or Rhode Island.

Further testing was done on a majority of these samples to confirm that these antibodies were related to this specific outbreak and not part of other common coronaviruses. The data showed that they “were obviously from SARSCoV-2 infected individuals.”

“The findings of this report suggest that SARS-CoV-2 infections may have been present in the U.S. in December 2019, earlier than previously recognized,” the authors wrote. 

The study provides major context about the virus and the way it may have been spreading, completely unknown to public health officials for quite some time. The authors of the study believe this information will kelp experts better understand the pandemic, how it started, and how it can be mitigated. 

“Understanding the dynamics of SARS-CoV-2 pandemic from early introduction throughout further progression will advance understanding of the epidemiology of this novel virus and inform allocation of resources and public health prevention interventions to mitigate morbidity and mortality associated with COVID-19,” the report said.

While the study provides incredible insight into the start of the coronavirus, the authors did also note there are limitations to what can be learned from it. For example, the data in the study should not be used to measure the magnitude of infections on a state or national level. It also cannot determine if these people came into contact with the virus from traveling, community spread, or another means of transmission. Though, a previous study of blood donors indicated that only around 3% had traveled outside of the U.S. in the 28 days prior to their donation.

Other Studies Suggest Earlier Spread

This is not the first study to suggest that COVID-19 was spreading this widely so soon. Dr. Eric Feigl-Ding, an epidemiologist and health economist explained on Twitter that this news matches up with a wastewater analysis, which found that the virus was potentially in Europe, specifically in Northern Italy, in mid-December. It also matches early indicator data that found excess flu illnesses in the province Wuhan is in during early December. 

Additionally, a separate report published in the Clinical Infectious Diseases journal last week found that the United States may have had significantly more COVID-19 cases than recorded. Since so many cases go unreported and undetected because many have no or mild symptoms, the study aimed to find the true number of cases the country may have seen at this point. 

“To estimate the cumulative incidence SARS-CoV-2 infections, symptomatic illnesses, and hospitalizations, we adapted a simple probabilistic multiplier model,” the study explained. “Laboratory-confirmed case counts that were reported nationally were adjusted for sources of under-detection based on testing practices in inpatient and outpatient settings and assay sensitivity.”

The authors found that only one out of every 2.5 hospitalized infections and one out of every seven non-hospitalized illnesses may have been nationally reported. This means that between February 27 and September 30, there may have been 52.9 million total infections in the U.S.

These cases, however, are unconfirmed and based on the model created. Currently, the U.S. has seen 13.6 million confirmed cases and lost 268,626 lives to the coronavirus.

See what others are saying: (Wall Street Journal) (NPR) (Bloomberg)

U.S.

FDA Authorizes Moderna and J&J COVID Vaccine Boosters, Approves Mix-and-Match Doses

Published

on

The approval will allow at-risk Americans who received Pfizer and Moderna vaccines to get any booster six months after their initial series and all Johnson & Johnson recipients 18 and older to do the same two months after their single-shot dose.


New FDA Authorization

The U.S. Food and Drug Administration (FDA) on Wednesday authorized boosters shots of Moderna and Johnson & Johnson COVID-19 vaccines and approved a mix-and-match strategy that will allow people who got one company’s shot to get a booster from a different maker.

The decision paves the way for millions of more at-risk Americans to get extra protection, and not just certain Pfizer recipients as previously approved by the FDA.

Under the authorization, people who received Moderna or Pfizer can get any one of the three booster shots six months after completing their initial series if they are 65 and older, at high risk of severe COVID, or face increased exposure because of their work.

Meanwhile, all J&J recipients 18 and older can get any of the approved vaccines two months after they received the one-shot jab.

Hazy Recommendations, For Now

Notably, the FDA did not recommend a certain combination of vaccines, nor did the agency say whether or not it would be more effective for people to stick with their original vaccine maker for their booster.

The new authorizations draw on a study from the National Institutes of Health (NIH), which found that there are no safety concerns with mixing boosters and that vaccine combinations were at least as effective in stimulating antibodies as matched vaccines.

In the case of J&J recipients, the NIH found that people actually had a higher boost from mixing either Moderna or Pfizer boosters.

However, some of the scientists who worked on the study said it should not be used to recommend one combination over another because the research was limited.

The Centers for Disease Control and Prevention (CDC), which determines vaccine recommendations, could issue more guidance on when and whether people should switch vaccine makers for their booster shots.

An advisory panel for the agency is meeting Thursday to discuss the new FDA authorizations and recommendations.

Once the panel makes its decision, the CDC director has the final say on the guidelines. If the agency agrees with the FDA’s decisions, the booster shots could be rolled out as soon as this weekend.

See what others are saying: (The New York Times) (NPR) (The Washington Post)

Continue Reading

U.S.

Paris Hilton Urges Lawmakers To Crack Down on Abusive Teen Treatment Facilities

Published

on

The heiress alleges that she was a victim of abuse in these types of centers for two years and wants to ensure that no child suffers through the same experience.


Paris Hilton Details Abuse Within “Troubled Teen Industry”

Socialite and entrepreneur Paris Hilton spoke outside of the U.S. Capitol on Wednesday to support the Accountability for Congregate Care Act, which is set to be introduced in the near future.

Hilton joined Rep. Ro Khanna (D-CA), Rep. Adam Schiff (D-CA), Rep. Rosa DeLauro (D-Conn.), and Sen. Jeff Merkley (D-Ore.) to advocate for the legislation, which aims to create a “bill of rights” for children in treatment and behavioral centers.

The heiress has alleged that she spent two of her teenage years in these types of facilities and was subject to rampant abuse. She is far from alone. 

During a press conference, Hilton said that one night when she was 16, she woke up to two large men in her bedroom forcing her out of her house. She said she screamed for help because she thought she was being kidnapped, but her parents watched as she was taken away to a “troubled teen” program. 

“Like countless other parents of teens, my parents had searched for solutions to my rebellious behavior,” she explained in an op-ed for The Washington Post this week. “Unfortunately, they fell for the misleading marketing of the ‘troubled teen industry’ — therapeutic boarding schools, military-style boot camps, juvenile justice facilities, behavior modification programs and other facilities that generate roughly $50 billion annually in part by pitching ‘tough love’ as the answer to problematic behavior.”

Hilton said she was sent to four different facilities where she was “physically and psychologically abused.” 

“I was strangled, slapped across the face, watched in the shower by male staff, called vulgar names, forced to take medication without a diagnosis, not given a proper education, thrown into solitary confinement in a room covered in scratch marks and smeared in blood and so much more,” she explained during the press conference. 

“At Provo Canyon School in Utah, I was given clothes with a number on the tag. I was no longer me, I was only number 127,” she continued. “I was forced to stay indoors for 11 months straight, no sunlight, no fresh air. These were considered privileges.”

Goals of the  Accountability for Congregate Care Act

Hilton claims that a lack of transparency and accountability has allowed this structure of abuse to thrive for decades. In some cases, she said it has taken children’s lives. Now, she wants Congress and President Joe Biden to act. 

“This bill creates an urgently needed bill of rights to ensure that every child placed into congregate care facilities is provided a safe and humane environment,” Hilton said of the Accountability for Congregate Care Act.

“This bill of rights provides protections that I wasn’t afforded, like access to education, to the outdoors, freedom from abusive treatment, and even the basic right to move and speak freely. If I had these rights and could have exercised them, I would have been saved from over 20 years of trauma and severe PTSD.” 

Foster children, children being treated for mental disorders, and other children in youth programs would be impacted by the bill.

Hilton was one of several survivors and advocates who fought for the legislation on Wednesday. Rep. Khanna thanked them for using their stories to fight for change. 

“No child should be subjected to solitary confinement, forced labor, or any form of institutional abuse,” he wrote. “Thanks to Paris Hilton, my colleagues & the survivors & advocates who joined us today to discuss how we can hold the congregate care industry accountable.”

While only Democratic legislators are currently sponsoring the bill, Hilton called for a bipartisan effort to fight for the rights of children. 

Ensuring that children are safe from institutional abuse isn’t a Republican or Democratic issue,” Hilton said. “It’s a basic human rights issue that requires immediate attention.”

See what others are saying: (The Washington Post) (The Hill) (NBC News)

Continue Reading

U.S.

Surgeons Successfully Test Pig Kidney Transplant on a Human

Published

on

The procedure has been hailed as a major scientific breakthrough that could eventually open the door to a renewable source of desperately needed organs.


Groundbreaking Procedure

Surgeons at the NYU Langone Transplant Institute revealed Tuesday that they temporarily attached a kidney from a genetically modified pig to a human patient and found that it worked normally.

The operation was the first of its kind and could one day lead to a vast supply of organs for those who are in severe need. According to the Associated Press, more than 90,000 people in the U.S. are in line for a kidney transplant. Each day, an average of 12 die while waiting.

With the family’s consent, the groundbreaking procedure was performed on a brain-dead patient who was kept alive on a ventilator.

According to the surgeons, the pig used was genetically engineered to grow an organ that wouldn’t produce a sugar that the human immune system attacks, which would then trigger the body to reject the kidney. 

The organ was connected to blood vessels on the patient’s upper leg, outside the abdomen, and it was observed for over 54 hours, with doctors finding no signs of rejection.

Concerns and Hurdles Ahead

While the procedure was successful, this doesn’t mean it’ll be available to patients anytime soon. Several questions about long-term functionality remain, and it will still have to go through significant medical and regulatory hurdles. 

Details of the procedure haven’t even been peer-reviewed or published in a medical journal yet, though there are plans for this. 

Experts are also considering the ethical implications of this type of animal-to-human transplant. For some, raising pigs to harvest their organs raises concerns about animal welfare and exploitation. Such medical procedures have already earned criticism from People for the Ethical Treatment of Animals, or PETA.

“Pigs aren’t spare parts and should never be used as such just because humans are too self-centered to donate their bodies to patients desperate for organ transplants,” PETA said in a statement, according to The New York Times.

On the other side of the debate are people like Dr. Robert Montgomery, the director of the N.Y.U. Langone Transplant Institute who performed the breakthrough procedure in September.

“I certainly understand the concern and what I would say is that currently about 40% of patients who are waiting for a transplant die before they receive one,” he told BBC.

“We use pigs as a source of food, we use pigs for medicinal uses – for valves, for medication. I think it’s not that different.”

See what others are saying: (CNN)(BBC) (The New York Times)

Continue Reading